Skip to main content

Closed

VKTX: Viking Therapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin0.0%

ROIC-135.8%

Financially safe

Stretched

Debt / equity0.01×

Interest coverage-70002.6×

Current ratio4.72×

Viking Therapeutics, Inc.

VKTXNASDAQ Capital Market·USD·Closed

Viking Therapeutics, Inc.

VKTXNASDAQ·USD·Closed

$31.74

−4.14%

$31.74

−$1.37 (4.14%)

52W Range

43thpctl

Volume

0.79×avg

Mkt Cap

3.70BUSD

P/E

-6.8TTM

Div Yield

–ann

52W Range

43thpctl

Volume

0.79×avg

Market Cap

3.70BUSD

P/E Ratio

-6.8TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings